AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triple-negative breast cancer

Abstract excerpt

Due to low success rates and long cycles of traditional drug development, the clinical tendency is to apply omics techniques to reveal patient-level disease characteristics and individualized responses to treatment. However, the heterogeneous form of data and uneven distribution of targets make drug discovery and precision medicine a non-trivial task. This study takes pyroptosis therapy for triple-negative breast...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bioinformatics and Genomic Networks
• Share to Cancer, Lipids, and Metabolism
• Share to Ferroptosis and cancer prognosis